$31M sweet spot round size
Most of their 109 investments are in rounds between $18M and $54M
2006
Mariana Oncology raised $175M on September 7, 2023
Investors: Surveyor Capital, Nextech Invest, Atlas Ventures, RA Capital Management, L.P. and Forbion
dualyx raised $44M on May 15, 2023
Investors: KU Leuven Innovation & Entrepreneurship, V-Bio Ventures, Andera Partners, High-Tech Gründerfonds, BGV (BioGeneration Ventures), VIB and Forbion
Complement Therapeutics raised $79M on April 17, 2023
Investors: Gimv, Hadean Ventures, PANAKES, BGV (BioGeneration Ventures), Cambridge Innovation Capital plc, Seroba-Kernel Ltd (Ireland) and Forbion
Noema Pharma raised $110M on March 7, 2023
Investors: UPMC Enterprises, Polaris Partners, Sofinnova Partners, The Invus Group, JEITO, Gilde Healthcare and Forbion
NewAmsterdam Pharma raised $235M on November 23, 2022
Investors: Life Sciences Partners (LSP), Frazier Healthcare Partners, Medicxi, RA Capital Management, L.P., GMT Capital and Forbion
CatalYm GmbH raised $51M on November 22, 2022
Investors: Brandon Capital Partners, coparion, JEITO, Vesalius Biocapital, BGV (BioGeneration Ventures), Bayern Kapital GmbH and Forbion
Inversago Pharma Inc raised $69M on October 17, 2022
Investors: adMare BioInnovations, Genesys Capital, JDRF T1D Fund and Forbion
VectivBio AG raised $125M on October 13, 2022
Investors: TCG X, Surveyor Capital, OrbiMed Advisors, Eventide Asset Management, Marshall Wace, Vivo Capital, Driehaus Capital Management LLC and Forbion
Pheon Therapeutics raised $68M on September 28, 2022
Investors: Research Corporation Technologies, Inc., Atlas Venture, Brandon Capital Partners and Forbion
F2G raised $70M on August 4, 2022
Investors: Sofinnova Partners and Forbion